(Q33930303)

30 July 2017

1 reference

title

Clinical application of therapeutic erythrocytapheresis (TEA). (English)

1 reference

30 July 2017

Valbonesi M

1

1 reference

30 July 2017

Bruni R

series ordinal

2

1 reference

30 July 2017

publication date

1 June 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

22

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

183-194

1 reference

Long-term treatment with interferon-alpha 2b for severe pruritus in patients with polycythaemia vera

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Treatment of polycythemia vera by isovolemic large-volume erythrocytapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Long-term survival analysis in hereditary hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

The effect of treatment on plasma uroporphyrin levels in cutaneous hepatic porphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

1 reference

7 January 2021

Exchange transfusion in severe anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Clinical and laboratory effects of long-term administration of hydroxyurea to patients with sickle-cell/beta-thalassaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Use of erythrocytapheresis in the treatment of patients with sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Prophylactic blood transfusion in maternal sickle cell syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Use of continuous flow erythrocytapheresis in pregnant patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Pseudomembranous colitis in sickle cell disease responding to exchange transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Blood transfusion in sickle cell disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Red cell exchange transfusion in severe HbS/beta-thalassemia double heterozygosis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Neocyte transfusion: a current perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Improved method for automated red cell exchange in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Multicomponent collection (MCS): a new trend in transfusion medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Autologous blood transfusion in pulmonary surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Hb Cheverly or alpha 2 beta 2 45(CD4)Phe replaced by Ser in an elderly Italian male

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Plasma exchange for a hemolytic crisis due to autoimmune hemolytic anemia of the IgG warm type

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Successful plasma exchange for a patient with chronic demyelinating polyneuropathy and cold agglutinin disease due to anti-Pra

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

ABO-incompatible bone-marrow transplantation: removal of red blood cells from donor marrow avoiding recipient antibody depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Apheresis for severe malaria complicated by cerebral malaria, acute respiratory distress syndrome, acute renal failure, and disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Erythrocyte exchange in cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Blood exchange [correction of exchance]-a rescue procedure for complicated falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Exchange transfusion for severe falciparum malaria?

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Treatment of transfusion-transmitted babesiosis by exchange transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Red cell exchange: treatment of babesiosis in a splenectomized patient

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

Treatment of babesiosis by red blood cell exchange in an HIV-positive, splenectomized patient

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2800%2900042-4

7 January 2021

10.1016/S0955-3886(00)00042-4

Identifiers

DOI

1 reference

30 July 2017

1 reference